Recombinant plasmids pMTIF-01A and pMTIF-P1B were constructed by fusing the metallothionein I promoter-regulatory region to the human beta 1 interferon (8, 9, 13) . Type I IFNs are further subdivided into leukocyte (alpha) and fibroblast (beta) IFNs on the basis of their major producer cells and antigenic properties (9, 13). Human beta 1 IFN (HuIFN-,l) and HuIFN-as share homology at both the nucleotide and amino acid levels, bind to a common receptor, and seem to have similar activities (8, 9, 13, 14) . IFNs are generally considered to be species specific (3). However, Recombinant plasmids pMTIF-P1A and pMTIF-P,B were constructed as shown in Fig. 1 moter-regulatory sequence. Because there is some evidence that a spurious ATG could interfere with translation initiation from an authentic transcription start site (6), the additional ATG was deleted in pMTIF-Pi1B (Fig. 1B) .
HuIFN-,31 in serum. These transgenic mice may be used as models to study IFN-induced responses and may serve as prototypes to generate disease-resistant animals.
Interferons (IFNs) are hormonelike proteins which are induced by numerous inducers (9, 13 (8, 9, 13) . Type I IFNs are further subdivided into leukocyte (alpha) and fibroblast (beta) IFNs on the basis of their major producer cells and antigenic properties (9, 13) . Human beta 1 IFN (HuIFN-,l) and HuIFN-as share homology at both the nucleotide and amino acid levels, bind to a common receptor, and seem to have similar activities (8, 9, 13, 14) . IFNs are generally considered to be species specific (3). However, HuIFN-P1 was shown to have significant activity in mouse cells (2, 3, 10, 16; S. Pestka, personal communication), and HuIFN-a, which is more effective in mouse cells than is HuIFN-p1, was shown to protect mice from encephalomyocarditis virus if administered before infection (15 moter-regulatory sequence. Because there is some evidence that a spurious ATG could interfere with translation initiation from an authentic transcription start site (6) , the additional ATG was deleted in pMTIF-Pi1B (Fig. 1B) .
To introduce the DNA into mouse germ lines, an EcoRIlinearized 6.5-kilobase (kb) pMTIF-P,A fragment and the 3.1-kb EcoRI-HindlIl fragment of pMTIF-P,B were separately microinjected into the pronuclei of fertilized mouse eggs (500 to 1,000 copies per egg). These eggs were subsequently transplanted into the oviducts of pseudopregnant foster recipient mice. When the resulting offspring were about 1 month old, a segment of the tail of each animal was removed and DNA was prepared from it. Transgenic mice were detected by DNA dot blot and Southern transfer hybridizations (Fig. 2) . Tail DNA (10 ,ug) (17) were cleaved by BglII and NcoI, respectively, and then the sticky ends on both plasmids were filled in by incubating the plasmids separately with deoxynucleoside triphosphates (N = A, T, G, and C) in the presence of the DNA polymerase I Klenow fragment. After purification, both plasmids were cleaved again by EcoRI, generating a 1.8-kb metallothionein I (MT-I) promoter-regulatory region fragment in pMK and a 4.4-kb fragment in pIFR containing an HuIFN-P1 genomic gene sequence, as well as an ampicillin resistance selective marker. These two fragments were isolated and purified by electroelution and then fused together by using DNA ligase. (B) pMTIF-P1A was linearized by NcoI, and the single-stranded ends were removed by S1 nuclease. Plasmid pMTIF-P1B was constructed by recircularizing the linearized, blunt-ended pMTIF-P,A with DNA ligase.
ization pattern, and some offspring from B9 inherited some, but not all, copies of the founder animal transgenes (Fig. 2) . When DNAs from B9 and most B9 offspring were digested with PvuII and EcoRI, a pattern of digestion fragments was observed on analysis of the Southern hybridization which includes a strong band at 3.1 kb, bands at 2.1 and 1.0 kb, and bands at 6.5, 4.5, 2.4, and 1.9 kb (Fig. 2) . Some offspring (B9-11, B9-16, and B9-17) showed only the bands at 2.1 and 1.0 kb, with very faint bands at 2.4 and 1.9 kb. These results suggest that two integration sites exist, one with a strong 3.1-kb internal fragment from PvuII digestion and displaying no digestion with EcoRI, probably because of destruction of the EcoRI sites from the ends of the inserted DNA fragment during the integration process, and a second integration site where the EcoRI site was retained, generating two (2.1-and 1.0-kb) fragments from the internal 3.1-kb PvuII fragment. The remaining bands probably represent junction fragments from the PvuII or EcoRI sites within the introduced sequences and these sites within the adjoining chromosomal sequences. Only mice containing both integration sites and clearly containing the distinct, complete MT/HuIFN-P1B sequences characterized by the 3.1-kb band were used in studies of IFN production and virus resistance.
When serum samples from the transgenic mice were collected and used in assays of antiviral activity, it was found that the sera from at least two strains of transgenic mice (A75 and B9) protected human WISH cells from a Blood was collected from mouse tails. The virus macroplaque reduction (VPR) assay was performed essentially as previously described (7).
b Blood was collected from the eyes and the hearts of the mice. The procedure for the MCPE assay was essentially as described in the legend to Fig. 3 , except that no anti-HuIFN-01 antibody was used.
See the legend to Fig. 3 for the assay conditions. vesicular stomatitis virus infection, whereas serum samples of nontransgenic mice failed to show any protection. Both a virus plaque reduction assay and a microtiter cytopathic effect (MCPE) assay were used to titrate the IFN concentrations in the serum samples of these strains of transgenic mice. The results of these assays are presented in Table 1 and show that the HuIFN-P1 concentrations in serum samples of strain A75 mice (containing pMTIF-P,A) were 71 ± 6 (virus plaque reduction) and 64 (MCPE) international reference units (IRU)/ml and those of strain B9 (containing the 3.1-kb pMTIF-P1B fragment) mouse serum samples were 759 + 47 (virus plaque reduction) and 256 (MCPE) IRU/ml. This result was consistent with a transient expression assay performed with these two plasmids in mouse L cells (data not shown), suggesting that it is likely that deletion of the additional ATG from pMTIF-P1A caused the increased HuIFN-P, concentration in serum samples of strain B9. The sera from these two expressing lines, when incubated with horse anti-HuIFN-P, antibody for 30 min at room temperature before the assay, failed to elicit any antiviral activity in the WISH cell-vesicular stomatitis virus assay (Table 1 and Fig. 3) . This antibody neutralization assay demonstrated that the protective activity comes from HuIFN-P1 in serum.
For the antibody neutralization assay, mouse serum was prepared from a sterile 200-pdl sample of blood. A 25-pJl volume of serum was used for each sample. The serum was mixed with 175 ,ul of Dulbecco modified Eagle medium (eightfold dilution) in the first well of each row and then serially diluted into subsequent wells in the same row by a factor of two by the following method. With a multipipette, 100 ,ul of Dulbecco modified Eagle medium was added to all of the wells except the first well, and then 100 ,ul of the serum-Dulbecco modified Eagle medium mixture was transferred from the first well into the second well. After thorough mixing, 100 ,ul of the mixture from the second well was transferred into the third well, etc., until the last well was reached. Then, 100 ,ul of human WISH cells ( (11) showed that the
